| Target ID: | dt1204 |
|---|---|
| CID: | 91663255 |
| Compound Name: | Sucroferric oxyhydroxide |
| Gene ID: | 6347 |
| Gene Name: | CCL2 |
| Species: | Homo sapiens (human) |
| PubMed IDs: | 17699372 |
| Action: | Ferric oxide, saccharated results in increased expression of CCL2 protein |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt1030 | 16739648 | He3286 | 6347 | CCL2 | Homo sapiens (human) | 17-ethynyl-5-androstene-3, 7, 17-triol results in decreased expression of CCL2 | Details |
| dt688 | 1549008 | Terbinafine | 6347 | CCL2 | Homo sapiens (human) | Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 protein]]|ptger2 protein promotes the reaction [terbinafine inhibits the reaction [TNF protein results in increased expre | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug157 | Iron Sucrose | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||